Quality of life in older adults with lymphomas

Overview

About this study

The purpose of this study is to identify factors important to decision-making for older adults with indolent lymphomas and to identify minimum clinically significant differences in QOL domains are important to older patients in their decision-making about clinical management.  And to characterize longitudinal health-related quality of life (QOL) for older adults with indolent lymphomas.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 65 and older at time of diagnosis
  • Diagnosed with an indolent lymphoma, and part of the Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
  • English-speaking, access to video conferencing

Exclusion Criteria:

  • Aggressive lymphoma diagnosis, age <65 at time of diagnosis

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 07/16/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mazie Tsang, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Jenelle Connolly

(480) 342-6782

Connolly.Jenelle@mayo.edu

More information

Publications

Publications are currently not available